FDA Cites Facilities in China, Japan, and India Post author:Sam Post published:February 14, 2017 Post category:Drug Industry Daily The FDA issued warning letters to four overseas manufacturers over GMP and other failures. Source: Drug Industry Daily You Might Also Like Research Roundup — June 2023 June 22, 2023 FDA Authorizes Second COVID-19 Booster Shots for Older Adults, Immunocompromised Patients March 29, 2022 Merck and Optum to Develop Value-Based Drug Pricing Agreements May 29, 2017
FDA Authorizes Second COVID-19 Booster Shots for Older Adults, Immunocompromised Patients March 29, 2022